Embolic Protection and Platelet Inhibition During Renal Artery Stenting - Embolic Protection and Platelet Inhibition During Renal Artery Stenting

Description:

The goal of the trial was to evaluate the change in glomerular filtration rate (GFR) after renal artery stenting (RAS) with Angioguard, RAS with abciximab, and RAS with Angioguard/abciximab, compared with RAS alone among patients with renal artery stenosis.